Maso Capital Partners Ltd - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
Maso Capital Partners Ltd ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$74,256,000
+0.3%
627,1110.0%28.61%
+41.6%
Q4 2020$74,068,000
-24.5%
627,111
-28.9%
20.20%
-63.1%
Q3 2020$98,071,000
+1.2%
882,411
-7.0%
54.82%
+40.2%
Q2 2020$96,931,000
-3.2%
948,629
+2.2%
39.10%
+50.7%
Q1 2020$100,161,000
+59.5%
928,016
+72.0%
25.94%
+28.5%
Q4 2019$62,798,000
+145.6%
539,597
+141.5%
20.20%
+119.8%
Q3 2019$25,573,000
+77.7%
223,400
+47.9%
9.19%
+21.7%
Q2 2019$14,394,000
-4.1%
151,034
-8.2%
7.55%
-26.8%
Q1 2019$15,011,000
+24.2%
164,500
+3.3%
10.32%
-32.0%
Q4 2018$12,085,000
+5.4%
159,200
+11.1%
15.18%
+35.9%
Q3 2018$11,464,000143,30011.16%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q3 2023
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders